Treatment of Infantile Spasms with Sodium Dipropylacetic Acid
- 1 October 1981
- journal article
- research article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 23 (5), 454-461
- https://doi.org/10.1111/j.1469-8749.1981.tb02018.x
Abstract
Infants (18) with infantile spasms were given sodium dipropylacetate at a dosage of 20 mg/kg per day. They were clinically examined before treatment and again after 1-3 yr of therapy. The short-term clinical response was excellent in 4 patients, good in 8, poor in 4 and there was no change in 2. At follow-up, 2 patients were clinically normal but 10 had severe and 6 had moderate mental retardation. Seven patients still had residual seizures. Since these results do not differ significantly from those obtained with hormonal treatment, using sodium dipropylacetate (which has less frequent and less severe side-effects than adreno-corticotropic hormone) as the only initial drug and using hormonal treatment only in unresponsive patients are suggested.This publication has 17 references indexed in Scilit:
- PANCREATITIS DUE TO VALPROIC ACIDThe Lancet, 1979
- Acute Hepatic Failure Associated with the Use of Sodium ValproateNew England Journal of Medicine, 1979
- Thrombocytopenia associated with sodium valproate treatmentAnnals of Neurology, 1979
- IgM platelet autoantibody due to sodium valproate.BMJ, 1978
- SODIUM VALPROATE AND PLATELET-COUNTThe Lancet, 1978
- Sodium valproate and thrombocytopenia.BMJ, 1976
- Sodium Valproate in the Treatment of Intractable Childhood EpilepsyDevelopmental Medicine and Child Neurology, 1975
- Long‐term Prognosis of 150 Cases of “West Syndrome”Epilepsia, 1973
- Prognostic Implications of Electroencephalographic Findings of Hypsarrhythmia in First Year of LifeBMJ, 1971
- Long‐Term Prognosis in Infantile Spasms: A Follow‐up Report on 112 casesDevelopmental Medicine and Child Neurology, 1970